Journal of Southern Medical University ›› 2022, Vol. 42 ›› Issue (3): 392-398.doi: 10.12122/j.issn.1673-4254.2022.03.11

Previous Articles     Next Articles

CD36 gene deletion reduces muscle insulin sensitivity in mice by up-regulating PTP1B expression

CHEN Lin, ZENG Han, QIN Hong, RUAN Xiongzhong, YANG Ping   

  1. Chongqing Key Laboratory of Lipid and Glucose Metabolism, Center for Lipid Research, Chongqing Medical University, Chongqing 400016, China
  • Online:2022-03-20 Published:2022-04-11

Abstract: Objective To investigate the effect CD36 deficiency on muscle insulin signaling in mice fed a normal-fat diet and explore the possible mechanism. Methods Wild-type (WT) mice and systemic CD36 knockout (CD36-/- ) mice with normal feeding for 14 weeks (n=12) were subjected to insulin tolerance test (ITT) after intraperitoneal injection with insulin (1 U/kg). Real-time PCR was used to detect the mRNA expressions of insulin receptor (IR), insulin receptor substrate 1/2 (IRS1/2) and protein tyrosine phosphatase 1B (PTP1B), and Western blotting was performed to detect the protein expressions of AKT, IR, IRS1/2 and PTP1B in the muscle tissues of the mice. Tyrosine phosphorylation of IR and IRS1 and histone acetylation of PTP1B promoter in muscle tissues were detected using co-immunoprecipitation (Co-IP) and chromatin immunoprecipitation (ChIP), respectively. Results CD36-/- mice showed significantly lowered insulin sensitivity with obviously decreased area under the insulin tolerance curve in comparison with the WT mice (P<0.05). CD36-/- mice also had significantly higher serum insulin concentration and HOMA-IR than WT mice (P<0.05). Western blotting showed that the p-AKT/AKT ratio in the muscle tissues was significantly decreased in CD36-/- mice as compared with the WT mice (P<0.01). No significant differences were found in mRNA and protein levels of IR, IRS1 and IRS2 in the muscle tissues between WT and CD36-/- mice (P>0.05). In the muscle tissue of CD36-/- mice, tyrosine phosphorylation levels of IR and IRS1 were significantly decreased (P<0.05), and the mRNA and protein levels of PTP1B (P<0.05) and histone acetylation level of PTP1B promoters (P<0.01) were significantly increased as compared with those in the WT mice. Intraperitoneal injection of claramine, a PTP1B inhibitor, effectively improved the impairment of insulin sensitivity in CD36-/- mice. Conclusion CD36 is essential for maintaining muscle insulin sensitivity under physiological conditions, and CD36 gene deletion in mice causes impaired insulin sensitivity by up-regulating muscle PTP1B expression, which results in detyrosine phosphorylation of IR and IRS1.

Key words: CD36; insulin sensitivity; muscle; PTP1B